Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Ebooks » Biomedical Sciences » Medicine » Cancer » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Biofuel Lifecycle Issues and Research
$165.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Overcoming the Barriers of the Central Nervous System: Novel Methods of Drug Delivery to Brain Cancer (pp. 1-21)
02.Brain Cancer Therapy and Surgical Interventions (Horizons in Cancer Research, Volume 27)
03.Horizons in Cancer Research. Volume 48
04.Tumor Budding in Colorectal Cancer: Recent Progress in Colorectal Cancer Research (E)
05.A Manual for Cervical Cancer Screening and Control: Principles, Practice and New Perspectives
06.Anticancer Drugs: Design, Delivery and Pharmacology
07.Aromatase Inhibitors: Types, Mode of Action and Indications
08.Cancer Biomarkers
09.Desmoplastic Small Round Cell Tumor
10.Experimental Models in Glioblastoma Research
Notifications more
NotificationsNotify me of updates to Aromatase Inhibitors: Types, Mode of Action and Indications
Tell A Friend
 
Tell someone you know about this product.
Aromatase Inhibitors: Types, Mode of Action and Indications $89.00
Editors: Jean R. Lamonte
Book Description:
Aromatase inhibitors (AI) are a class of drugs used in the treatment of breast cancer and ovarian cancer in postmenopausal women. Aromatase is an enzyme that synthesizes estrogen and aromatase inhibitors block the synthesis of estrogen, which is needed in some cancers to grow. As breast tissue is stimulated by estrogens, decreasing their production is a way of suppressing recurrence of the breast tumor tissue. In contrast to pre-menopausal women, in whom most of the estrogen is produced in the ovaries, in post-menopausal women most of the body's estrogen is produced in the adrenal gland from the conversion of androgens. Investigations are ongoing to look for other applications and researchers continue to study aromatase inhibitors as a way to stimulate ovulation or suppress estrogen production in endometriosis. This new book presents the latest research from around the world in this dynamic field.

Table of Contents:
Preface

Anti-Estrogen Agents: Aromatase Inhibitors; Past, Present and Future
(Masanori Shimodaira, and Tomohiro Nakayama, Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan, and others)

Aromatase Inhibitors: Types, Mode of Action and Indications
(Helena Aguilar, MD, and Ander Urruticoechea, MD., Ph.D., Institut Català d’Oncologia. Barcelona. Spain)

Aromatase Inhibitors
(Mosammat Rashida Begum, Maruf Siddiqui, Dhaka Medical College and Hospital, Dhaka, Bangladesh)

Upfront vs. Sequential Aromatase Inhibitors: An Ongoing or Settled Debate?
(Tallal Younis and Chris Skedgel, Queen Elizabeth II Health Sciences Centre, Department of Medicine at Dalhousie University, Halifax, Nova Scotia, and others)

Aromatase Expression in the Endometrium and its Role in the Development of Uterine Pathology
(Hugo Maia Jr., Julio Casoy, Jorge Valente Filho and Elsimar Coutinho.
Centro de Pesquisas e Assistência em Reprodução Humana (CEPARH)
Salvador, Bahia, Brazil)

Aromatase Inhibitors for the Medical Treatment of Endometriosis
(Kaei Nasu, Akitoshi Tsuno, Akitoshi Yuge, Masakazu Nishida, Hisashi Narahara,
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan)

An Update of the Use of Aromatase Inhibitors in the Management of Breast Cancer
(S. Tang, D.A.L. Morgan, K.L. Cheung, Division of Breast Surgery, University of Nottingham, Department of Oncology, Nottingham University Hospitals, UK)

Aromatase Inhibitors in Ovulation Induction: Myth or Reality?
(Nikolaos P. Polyzos, Spyridon Tzioras, Davide Mauri, Maria Tsappi, Antonis Valachis, Charalambos Dritsas, Kamposioras Konstantinos, Charalambos Panou, Lamprini Tsali,
Panhellenic Association for Continual Medical Research (PACMeR), Section of Obstetrics and Gynaecology, Bolos, Greece)

The Use of Aromatase Inhibitors in Ovarian Cancer and Identification of Responsive Tumors
(S.P. Langdon, G. Walker, D. Faratian, C. Gourley, A.R.W. Williams, I. Um, J.F. Smyth, D.J. Harrison, Edinburgh Breakthrough Breast Unit, Institute for Genetics and Molecular Medicine, University of Edinburgh, United Kingdom)

Index

   Series:
      Cancer Etiology, Diagnosis and Treatments
   Binding: ebook
   Pub. Date: 2009 3rd Quarter
   ISBN: 978-1-61668-665-9
   Status: AV
  
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
  
Available Options:
Version:
Special Focus Titles
01.Isoprostanes and Neuroprostanes: Production and Role in Different Pathologies
02.Women and War: Opening Pandora’s Box - Intimate Relationships in the Shadow of Traumatic Experiences
03.Deciphering Organic Foods: A Comprehensive Guide to Organic Food Production, Consumption, and Promotion
04.Developing Critical Thinking: A Multi-Dimensional Approach in the Context of South Africa
05.Photonic Crystals: Characteristics, Performance and Applications
06.Embodied Cognition: Theories and Applications in Education Science
07.Slovenia: Social, Economic and Environmental Issues
08.Chemoradiotherapy: Concurrent Uses, Efficacy and Impact on Prognosis
09.Autism Patents and Beyond
10.Advances in Carcinogenesis Research
11.Digital Stories and Their Integration in Early Childhood and Primary Education: Teaching Scenarios and Practical Ideas
12.Azobenzene: Aspects, Applications and Research

Nova Science Publishers
© Copyright 2004 - 2017

Aromatase Inhibitors: Types, Mode of Action and Indications